Tim Middleton
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 12
- Hepatology 11
- Hepatitis C virus research 11
- Co-authors
- Dale J. Kempf (9 shared papers)Warren M. Kati (13 shared papers)Jennifer M. Martin (1 shared paper)Bill Sugden (1 shared paper)Akhteruzzaman Molla (9 shared papers)David A. Egan (1 shared paper)Philip J. Hajduk (1 shared paper)Stephen W. Fesik (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (7 papers)SLAS DISCOVERY (2 papers)Analytical Biochemistry (2 papers)BMJ Open Diabetes Research & Care (1 paper)Advances in virus research (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Tim Middleton
19 papers receiving 470 citations
Peers
Comparison fields: 5 of 66
- Hepatology 180
- Infectious Diseases 155
- Virology 27
- Epidemiology 130
- Computational Theory and Mathematics 50
Countries citing papers authored by Tim Middleton
This map shows the geographic impact of Tim Middleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Middleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Middleton more than expected).
Fields of papers citing papers by Tim Middleton
This network shows the impact of papers produced by Tim Middleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Middleton. The network helps show where Tim Middleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Middleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 128 | |
| 2 | 1991 | 55 | |
| 3 | 2018 | 45 | |
| 4 | 2007 | 39 | |
| 5 | 2005 | 28 | |
| 6 | 2006 | 27 | |
| 7 | 2007 | 25 | |
| 8 | 2006 | 24 | |
| 9 | 2002 | 24 | |
| 10 | 2006 | 22 | |
| 11 | 2007 | 17 | |
| 12 | 2007 | 16 | |
| 13 | 2008 | 13 | |
| 14 | 2007 | 9 | |
| 15 | 1985 | 9 | |
| 16 | 2011 | 7 | |
| 17 | 2003 | 6 | |
| 18 | 2023 | 4 | |
| 19 | 2002 | 1 | |
| 20 | 2013 | 0 |
About Tim Middleton
Tim Middleton is a scholar working on Infectious Diseases, Hepatology, Molecular Biology, Organic Chemistry and Epidemiology, having authored 20 papers that have together received 499 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers), Quinazolinone synthesis and applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Biochemical and Molecular Research (3 papers), Hepatitis B Virus Studies (3 papers), HIV Research and Treatment (2 papers) and Molecular Biology Techniques and Applications (2 papers). The work is most often cited by research in Hepatology (180 citations), Infectious Diseases (155 citations), Virology (27 citations), Epidemiology (130 citations) and Computational Theory and Mathematics (50 citations). Tim Middleton has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Dale J. Kempf, Warren M. Kati, Jennifer M. Martin, Bill Sugden, Akhteruzzaman Molla, David A. Egan, Philip J. Hajduk, Stephen W. Fesik, O. Kenrik Duru and Thomas F. Holzman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, SLAS DISCOVERY, Analytical Biochemistry, BMJ Open Diabetes Research & Care and Advances in virus research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.